Compounds > ha 1004

ha 1004 and cyclic gmp

ha 1004 has been researched along with cyclic gmp in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's4 (50.00)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondratyev, AD; Posypanova, GA; Severin, SE1
Häyry, P; Leszczynski, D1
Mattila, P; Renkonen, R; Turunen, JP1
Hidaka, H; Inagaki, M; Ishikawa, T; Watanabe, M1
Chik, CL; Ho, AK; Karpinski, E; Li, B; Liu, QY1
Ahern, GP; Jackson, MB; Klyachko, VA1
Cebrat, M; Kalas, W; Matuszyk, J; Strzadala, L1
Fukui, H; Horio, S; Kawakami, N; Miyoshi, K1

Other Studies

8 other study(ies) available for ha 1004 and cyclic gmp

ArticleYear
Effect of protein kinase modulators on the induction of morphological differentiation of pheochromocytoma PC12 cells by nerve and fibroblast growth factors.
    Biotechnology and applied biochemistry, 1990, Volume: 12, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Axons; Cell Differentiation; Cyclic AMP; Cyclic GMP; Drug Synergism; Fibroblast Growth Factors; Isoquinolines; Nerve Growth Factors; Pheochromocytoma; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Rats; Sulfonamides; Tumor Cells, Cultured

1990
Effect of granulocyte-macrophage colony stimulating factor on endothelial antigenicity.
    Human immunology, 1990, Volume: 28, Issue:2

    Topics: Animals; Colony-Stimulating Factors; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Histocompatibility Antigens Class I; Interferon-gamma; Isoquinolines; Myocardium; Prostaglandins; Protein Kinase Inhibitors; Rats; Recombinant Proteins; Sulfonamides

1990
cAMP mediates IL-1-induced lymphocyte penetration through endothelial monolayers.
    Journal of immunology (Baltimore, Md. : 1950), 1990, Dec-15, Volume: 145, Issue:12

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcium; Cell Movement; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic GMP; Cycloheximide; Dactinomycin; Endothelium, Vascular; Gene Expression; In Vitro Techniques; Inflammation; Interleukin-1; Isoquinolines; Lymphocytes; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Inbred Strains; Signal Transduction; Sulfonamides

1990
Relaxation of vascular smooth muscle by HA-1004, an inhibitor of cyclic nucleotide-dependent protein kinase.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 235, Issue:2

    Topics: Adenosine Triphosphatases; Animals; Atropine; Calcimycin; Calcium Chloride; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Isoquinolines; Kinetics; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Phentolamine; Phenylephrine; Propranolol; Protein Kinase Inhibitors; Rabbits; Sulfonamides

1985
cGMP inhibits L-type Ca2+ channel currents through protein phosphorylation in rat pinealocytes.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1995, Volume: 15, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Isoquinolines; Male; Nifedipine; Nitroprusside; Norepinephrine; Patch-Clamp Techniques; Phosphorylation; Pineal Gland; Piperazines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Thionucleotides

1995
cGMP-mediated facilitation in nerve terminals by enhancement of the spike afterhyperpolarization.
    Neuron, 2001, Sep-27, Volume: 31, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Action Potentials; Alkaloids; Animals; Calcium; Carbazoles; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; Indoles; Ion Channel Gating; Ion Transport; Ionomycin; Isoquinolines; Large-Conductance Calcium-Activated Potassium Channels; Nerve Tissue Proteins; Neuronal Plasticity; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Oxadiazoles; Patch-Clamp Techniques; Photolysis; Pituitary Gland, Posterior; Potassium; Potassium Channels; Potassium Channels, Calcium-Activated; Quinoxalines; Signal Transduction; Sodium; Sodium Channels; Sulfonamides; Thionucleotides

2001
HA1004, an inhibitor of serine/threonine protein kinases, restores the sensitivity of thymic lymphomas to Ca2+-mediated apoptosis through a protein kinase A-independent mechanism.
    International immunopharmacology, 2002, Volume: 2, Issue:4

    Topics: Animals; Apoptosis; Calcium; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Isoquinolines; Lymphoma; Mice; Protein Serine-Threonine Kinases; Signal Transduction; Sulfonamides; Thymus Neoplasms; Tumor Cells, Cultured

2002
Inhibition of histamine H1 receptor downregulation by KT5823, a protein kinase G inhibitor.
    Methods and findings in experimental and clinical pharmacology, 2003, Volume: 25, Issue:5

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Carbazoles; CHO Cells; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Down-Regulation; Enzyme Activators; Histamine; Indoles; Isoquinolines; Protein Kinase C; Receptors, Histamine H1; Sulfonamides; Thionucleotides; Time Factors

2003